Charles Ornstein

Managing Editor, Local

Photo of Charles Ornstein

Charles Ornstein is managing editor, local, overseeing ProPublica’s local initiatives. These include offices in the Midwest, South, Southwest, a joint initiative with the Texas Tribune and the Local Reporting Network, which works with local news organizations to produce accountability journalism on issues of importance to their communities. From 2008 to 2017, he was a senior reporter covering health care and the pharmaceutical industry. He then worked as a senior editor and deputy managing editor.

Prior to joining ProPublica, he was a member of the metro investigative projects team at the Los Angeles Times. In 2004, he and Tracy Weber were lead authors on a series on Martin Luther King Jr./Drew Medical Center, a troubled hospital in South Los Angeles. The articles won the 2005 Pulitzer Prize for public service, the Robert F. Kennedy Journalism Award, and the Sigma Delta Chi Award for Public Service.

In 2009, he and Weber worked on a series of stories that detailed serious failures in oversight by the California Board of Registered Nursing and nursing boards around the country. The work was a finalist for the 2010 Pulitzer Prize for public service.

Projects edited or co-edited by Ornstein have won the Pulitzer Prize for public service, the Selden Ring Award for Investigative Reporting, the Scripps Howard Impact Award, the IRE Award, the Online Journalism Award and other major journalism honors.

He previously worked at the Dallas Morning News, where he covered health care on the business desk and worked in the Washington bureau. Ornstein is a past president of the Association of Health Care Journalists and an adjunct journalism professor at Columbia University. Ornstein is a graduate of the University of Pennsylvania.

Dollars for Dudes: Almost No Women Among Medical Industry's Top-Paid Speakers, Consultants

The causes are not clear, but men account for more than 90 percent of the 300 doctors who received the most money from drug and medical device companies, according to new federal data.

$1.1 Billion in Drug, Device Payments to Doctors Not Included in New Federal Database

The new Open Payments database of industry payments to doctors and teaching hospitals is more incomplete than previously known.

Analysis: Government's New Doctor Payments Website Worthy of a Recall

Our health reporter Charles Ornstein takes a test drive using the federal government's new website for drug and device payments. He finds it virtually unusable.

Our First Dive Into the New Open Payments System

The government's data on payments to doctors and hospitals by drug and device makers is incomplete and hard to penetrate – but here's a first look.

What to be Wary of in the Govt's New Site Detailing Industry Money to Docs

The government's new website on drug and device company ties to doctors will be incomplete and may be misleading — for now.

What We've Learned From Four Years of Diving Into Dollars for Docs

Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.

A New Way Insurers are Shifting Costs to the Sick

By charging higher prices for generic drugs that treat certain illness, health insurers may be violating the spirit of the Affordable Care Act, which bans discrimination against those with pre-existing conditions.

One Drug. Two Prices. A Reporter Struggles to Find Out the Cost of His Son’s Prescription

$15 or $30? Health reporter Charles Ornstein is charged two different prices for the same drug. Which one is right? His effort to find out illustrates consumer frustrations with the health care system.

More Data to Be Withheld from Database of Physician Payments

The federal government won’t release data next month on some research payments to doctors. Health officials had acknowledged previously that the database wouldn’t include one-third of payments made by pharmaceutical and medical device companies.

Government Will Withhold One-Third of the Records from Database of Physician Payments

Many payments to doctors made by pharmaceutical and medical device companies will not be included in the public release of the database next month. Federal officials cite data inconsistencies, say records will be posted next June.

Illinois Suspends Medical License of Leading Prescriber of Antipsychotic Drugs

For years, Dr. Michael Reinstein prescribed the powerful drug clozapine more than any other doctor in Medicare or Medicaid. His patterns were the subject of two ProPublica articles and he faces a federal civil lawsuit alleging health care fraud.

Suspicious Prescriptions for HIV Drugs Abound in Medicare

The inspector general of the U.S. Department of Health and Human Services finds Medicare spent tens of millions of dollars in 2012 for HIV drugs there’s little evidence patients needed. A 77-year-old woman with no record of HIV got $33,500 of medication.

Top Acthar Prescribers in Medicare Have Ties to Its Maker

The top four prescribers of the drug were promotional speakers, researchers or consultants.

The Obscure Drug With a Growing Medicare Tab

Experts question the effectiveness of H.P. Acthar Gel, a drug made from pigs’ pituitary glands. Yet it cost Medicare more than $141 million in 2012, up from $7 million in 2008.

Glitch Prompts Temporary Shutdown of Pharma Payment Verification System

The government had to take offline its system for doctors to verify payments from drug companies after at least one doctor had payments attributed to him that actually went to someone else.

Are Patient Privacy Laws Being Misused to Protect Medical Centers?

A 1996 law known as HIPAA has been cited to scold a mom taking a picture of her son in a hospital, to keep information away from police investigating a possible rape at a nursing home, and to threaten VA whistleblowers.

Even After Open Enrollment, Activity Remains Unexpectedly High on Federal Health Insurance Exchange

New federal data, obtained by ProPublica under the Freedom of Information Act, shows nearly 1 million insurance transactions since mid-April.

Error: You Have No Payments from Pharma

Doctors checking a soon-to-be-unveiled federal website that will publicly list drug company payments are encountering error messages if they have not accepted industry money.

Why Are Obstetricians Among the Top Billers for Group Psychotherapy in Illinois?

Illinois leads the country in group psychotherapy sessions in Medicare, and some top billers aren’t mental health specialists. The state’s Medicaid program has cracked down, but federal officials have not.

Fanny Pack Mixup Unravels Massive Medicare Fraud Scheme

Two secretaries in a doctor’s office have pleaded guilty and a pharmacy owner faces charges in a scam that Medicare allowed to thrive for more than two years.

Follow ProPublica

Latest Stories from ProPublica